NYSE:TEVA
Teva Pharmaceutical Industries Limited Stock News
$14.05
-0.0500 (-0.355%)
At Close: Apr 30, 2024
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
What To Expect From Teva Pharmaceutical In 2023 With A New CEO
02:37pm, Wednesday, 15'th Feb 2023
Anda's revenue generated $450 million for the company in the last three months of 2022, up $95 million from Q4 2022, driven by substantially increased demand for the company's services. Teva's Europea
Top Trades of David Abrams' Firm in the 4th Quarter
04:54pm, Monday, 13'th Feb 2023
David Abrams (Trades, Portfolio), founder of Abrams Capital Management, disclosed in a regulatory portfolio update filing that his firm's top trades during the fourth quarter included the transfer of
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
10:34am, Monday, 13'th Feb 2023
Axsome Therapeutics (NASDAQ: AXSM ) stock is taking a beating on Monday as rival Teva Pharmaceutical (NYSE: TEVA ) prepares a generic depression drug. According to a filing with the U.S. Securities an
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
01:29pm, Thursday, 09'th Feb 2023 Zacks Investment Research
TEVA reports mixed Q4 results, beating earnings estimates, while sales slightly miss estimates. Stock down post earnings release.
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
09:48am, Thursday, 09'th Feb 2023
TEVA reports mixed Q4 results, beating earnings estimates, while sales slightly miss estimates. Stock down post earnings release.
Teva Pharmaceutical Industries (TEVA) Q4 2022 Earnings Call Transcript
09:30pm, Wednesday, 08'th Feb 2023 The Motley Fool
TEVA earnings call for the period ending December 31, 2022.
Why Teva Pharmaceutical Stock Is Sliding Today
05:01pm, Wednesday, 08'th Feb 2023 The Motley Fool
Investors were disappointed with the drugmaker's 2023 outlook.
Teva Pharmaceutical Industries Limited (TEVA) Q4 2022 Earnings Call Transcript
12:21pm, Wednesday, 08'th Feb 2023
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q4 2022 Earnings Conference Call February 8, 2023 8:00 AM ET Company Participants Ran Meir - Senior Vice President, Head of Investor Relations Richa
Why Teva Pharmaceutical Stock Is Sliding Today
12:01pm, Wednesday, 08'th Feb 2023
Investors were disappointed with the drugmaker's 2023 outlook.
Nasdaq Bear Market: 3 Tantalizing Value Stocks That Can Double Your Money by 2026
10:21am, Wednesday, 08'th Feb 2023 The Motley Fool
These profitable companies are exceptionally cheap and ripe for the picking, following a 33% decline in the Nasdaq Composite.
Nasdaq Bear Market: 3 Tantalizing Value Stocks That Can Double Your Money by 2026
05:21am, Wednesday, 08'th Feb 2023
These profitable companies are exceptionally cheap and ripe for the picking, following a 33% decline in the Nasdaq Composite.
Biotech Stocks Reward Shareholders Who Handle The Bumpy Ride
02:56pm, Friday, 27'th Jan 2023
Biotech and medical device stocks can be highly profitable. One of these volatile issues just catapulted over 41%.
Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now?
02:40pm, Friday, 27'th Jan 2023 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is Teva Pharmaceutical Industries (TEVA) a Great Value Stock Right Now?
11:17am, Friday, 27'th Jan 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
